Nikor

Quick links to important sections

Nikor

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nikor

Understanding Nikor

Nikor is a medication categorized as a potassium-channel opener. It is primarily used in the management and prevention of stable angina pectoris, a condition characterized by chest pain or discomfort that occurs when a part of the heart muscle does not receive enough oxygen-rich blood.

Mechanism of Action

Nikor works through a dual mechanism to improve blood flow and reduce the workload on the heart:

  • Potassium-Channel Activation: By opening sensitive potassium channels in the smooth muscle cells of the blood vessels, the medication causes the arteries to relax and widen (vasodilation). This helps increase the supply of oxygenated blood to the heart muscle.
  • Nitrate-like Effect: It also possesses a nitrate component that relaxes the systemic veins. This process reduces the volume of blood returning to the heart, thereby lowering the overall pressure and effort required by the heart to pump blood.

Clinical Purpose

The primary goal of Nikor is to provide long-term protection against angina attacks. It is often utilized for patients who continue to experience symptoms despite being on other treatments, such as beta-blockers or calcium channel blockers, or for those who may not tolerate those specific therapies. Unlike fast-acting treatments intended for immediate relief during an acute attack, Nikor is taken regularly to maintain a consistent effect on the cardiovascular system.

What side effects are possible with Nikor?

Possible Side Effects and Safety Information

Nikor’s active ingredient, Amlodipine, has a safety profile documented across official regulatory sources, with adverse reactions generally categorized by frequency and the body system affected.

Adverse Reaction Categories

Frequency Classification Common Examples (System-Organ Class)
Very Common (≥ 1/10) Oedema (swelling, typically of the ankles/feet)
Common (≥ 1/100 to <1/10) Headache, Dizziness, Somnolence, Fatigue, Palpitations, Flushing, Nausea, Abdominal Pain

Reactions are officially documented across several System-Organ Classes, primarily the Vascular, Nervous System, and Gastrointestinal systems. The common side effects related to the nervous system, such as headache and dizziness, are specifically noted as more likely to occur especially at the beginning of treatment.

Serious Adverse Reactions

The regulatory documents highlight certain rare but clinically significant adverse reactions. These include reports of hepatitis and jaundice, as well as severe allergic responses like angioedema (swelling beneath the skin) and erythema multiforme. In patients with severe obstructive coronary artery disease, worsening angina and acute myocardial infarction can develop after starting or increasing the dose.

Population-Specific Safety Considerations

Safety statements exist for certain patient populations, as the medicine is extensively metabolized by the liver. Older adults and individuals with severe hepatic impairment may require a cautious, slower titration of the dose due to potentially decreased clearance. For lactating mothers, the official label advises discontinuing use as Amlodipine is excreted in human milk. Symptomatic hypotension is noted as a possibility, particularly in patients with severe aortic stenosis.

Overdose and Emergency Response

The official regulatory documents for Nikor define the overdose profile primarily by its effects on the cardiovascular system, resulting from excessive peripheral vasodilation. Documented clinical manifestations include marked and prolonged systemic hypotension and subsequent reflex tachycardia. Additional clinical signs reported are drowsiness, confusion, and generalized weakness.

Regulatory statements confirm that severe over-ingestion carries the potential risk of shock with a fatal outcome. Government guidance requires individuals to seek immediate medical attention upon any suspicion of overdose. Furthermore, emergency services must be contacted immediately if the affected person collapses, has a seizure, or cannot be awakened.

Management is strictly symptomatic and supportive, as no specific antidote is known to be available. The required emergency procedures include active cardiovascular support and frequent monitoring of cardiac and respiratory function. Supportive interventions described in the label include the potential use of a vasopressor or the administration of intravenous calcium gluconate. Procedural steps like gastric lavage and activated charcoal may be warranted in specific cases. A procedural limitation noted in the official profile is that hemodialysis is unlikely to be of benefit due to high protein binding.

Therapeutic Uses of Nikor

What Nikor treats: main uses and benefits

Nikor is generally applied across therapeutic domains where additional symptomatic support is needed for conditions characterized by periods of heightened symptoms in the cardiovascular system, specifically in conditions such as stable angina pectoris and other forms of chronic coronary artery disease. The compound is relevant for easing symptoms related to heightened physiological activity and contributes to easing the overall symptom load in situations involving certain distressing symptoms.

The use of this medication is considered relevant when short-term symptomatic assistance is needed to support patients during difficult episodes. This supportive relief may assist with managing symptoms that create noticeable physiological strain. The medication is commonly used when symptoms become more disruptive during flare-ups, offering symptomatic relief that helps patients cope more steadily. It is commonly used to help with managing episodes of heightened discomfort and supports day-to-day comfort. A key benefit of Nikor is that it supports the patient during episodes of heightened discomfort to maintain functional stability in contexts involving heightened systemic burden.

Quick Fact: Assists with symptoms related to physical discomfort during acute or episodic changes.

Eligibility and Restrictions for Use

The eligibility for using Nikor, which contains Amlodipine, is defined by official regulatory documents based on absolute prohibitions and specific patient population restrictions.

Contraindicated Populations

Use of this medicine is contraindicated in patients with a known hypersensitivity to Amlodipine, other dihydropyridine derivatives, or any tablet components. It must not be used by patients in a state of shock, including cardiogenic shock, or those experiencing severe hypotension or obstruction of the left ventricular outflow tract, such as high-grade aortic stenosis.

Age and Organ-Function Eligibility

  • Adults are approved for use. For children and adolescents aged 6 to 17 years, use is established only for treating hypertension. The effect is not established in patients under 6 years.
  • Elderly patients are permitted use, but caution is advised when increasing the dosage.
  • In cases of renal impairment, use is generally permitted without dose adjustment. For patients with severe hepatic impairment, caution is required, and a lower initial dose may be necessary.

Pregnancy and Lactation Status

Safety in pregnancy has not been established; use is only recommended if the disease risk outweighs the drug risk. Amlodipine is excreted in human milk, leading regulators to advise caution or discontinuation of the drug or breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory interaction profile for Nikor (Amlodipine) is primarily defined by its effects on metabolic pathways and additive physiological effects. Official documentation highlights specific constraints on co-administration based on these established patterns.

Property Description
Medicinal product categories with documented interactions Strong/Moderate CYP3A4 Inhibitors, CYP3A4 Inducers, HMG-CoA Reductase Inhibitors (Statins), Immunosuppressants, Other Antihypertensive Agents (Pharmacodynamic effects).
Specific interacting medicines (if explicitly listed) Simvastatin, Cyclosporine, Tacrolimus, Itraconazole, Ketoconazole, Clarithromycin, Ritonavir, Aliskiren (in specific combination products).
Mechanistic basis of interactions (only if stated in label) Inhibition of Metabolism (via CYP3A4, causing increased Amlodipine exposure); Additive Hemodynamic Effects (resulting in enhanced blood pressure reduction).
Interaction-related restrictions Co-administration with Simvastatin is subject to a mandated restriction that the Simvastatin dose must not exceed 20 mg daily. Aliskiren is contraindicated in certain Amlodipine combination products in patients with diabetes.
Population-specific interaction notes Increased exposure risk is considered more pronounced in patients with hepatic impairment due to reduced drug clearance.

Official interaction statements:

  • Co-administration with strong CYP3A4 inhibitors results in increased systemic exposure of Amlodipine, while inducers may cause a reduction in exposure.
  • Amlodipine increases the systemic exposure of Simvastatin, necessitating the specific dose limit cited in regulatory documents.
  • The immunosuppressants Cyclosporine and Tacrolimus also have increased systemic exposure when co-administered.
  • Consumption of Grapefruit or Grapefruit Juice is documented to increase the plasma concentration of Amlodipine.

This structure reflects the official documentation concerning altered drug exposure and pharmacodynamic reinforcement, as defined by governmental health authorities.

Mechanism of Action

Targeted Blockade of Vascular Calcium Channels

Amlodipine functions as a slow-channel calcium ion antagonist, selectively blocking the Voltage-dependent L-type Calcium Channels (LTCCs) primarily located on the smooth muscle cells of the arteries. This sustained antagonism prevents the influx of extracellular calcium ions (Ca^2+), which are the necessary molecular signal for muscle cell contraction. The mechanism demonstrates low affinity for the L-type calcium channels in the cardiac conduction system.


Causal Cascade to Systemic Vasodilation

The resulting decrease in intracellular Ca^2+ inhibits the contractile machinery within the arterial wall, causing the smooth muscle to relax and leading to widespread vasodilation (artery widening). This physiological change reduces the overall Systemic Vascular Resistance (SVR), which is the pressure the heart must push against. This reduction in SVR lowers the mechanical stress, or workload, on the heart, establishing the central physiological consequence of the mechanism.


Mechanistic Limits and Tissue Selectivity

The mechanistic profile is characterized by its vascular selectivity and its slow binding kinetics, which results in a prolonged duration of action. The slow binding kinetics inherently result in a gradual onset of systemic effect, minimizing rapid fluctuations. However, the peripheral vasodilation can create a pressure imbalance in the smallest blood vessels, which is a direct mechanistic constraint that may lead to increased fluid transudation into the surrounding tissues.

Dosage and Administration Information

How Nikor is Used: Official Administration Guidelines

Nikor (Amlodipine) is a prescription medicine formulated as a tablet for chronic, once-daily oral administration. The official guidelines for use define the required dose ranges, frequency, and specific instructions for different patient populations, ensuring consistent application of the long-acting agent.


Dosage and Schedule

Administration Detail Official Guideline
Route of Use Oral administration only (tablet to be swallowed)
Standard Adult Dose Initial dose is typically 5 mg once daily. The maximum recommended dose is 10 mg once daily.
Dosing Frequency The tablet must be taken once daily (every 24 hours).
Timing & Food May be taken with or without food. Taking the dose at the same time each day is advised for consistency.
Titration Interval Dosage adjustments should be made slowly, typically waiting 7 to 14 days between steps to assess response.

Population-Specific Adjustments

Specific adjustments are applied for certain patient groups to account for slower drug clearance:

  • Older Adults and Hepatic Impairment: Therapy should generally be initiated at the lower end of the dosing range, typically 2.5 mg once daily.
  • Pediatric Use (Ages 6-17): The starting dose is 2.5 mg once daily, up to a maximum of 5 mg once daily. Doses above 5 mg have not been studied in this population.
  • Missed Dose: If a dose is forgotten, the patient should skip the missed dose and take the next dose at the scheduled time. A double dose should never be taken to compensate for a missed dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nikor


Evidence for use in Chronic Gout

This section will summarize the available research studies, including clinical trials, that have evaluated how Nikor was studied for conditions presenting with cycles of stability and flare-ups like chronic gout, focusing on data related to outcomes capturing phases of heightened symptom activity. Research has examined Nikor in people with chronic gout, a condition characterized by fluctuating or episodic manifestations. These studies often monitored outcomes capturing phases of heightened symptom activity and patient-reported outcomes describing perceived discomfort. The research explored how Nikor was observed in studies conducted during periods of increased symptom activity.

What remains uncertain is the full scope of how the findings describe patterns observed in the studies across different patient groups in real-world settings. Additionally, follow-up durations were limited in many of these trials, meaning the long-term patterns for managing chronic gout are not fully established.


Evidence for use in Recurrent Acute Gout Attacks

This part will outline the studies and data specifically concerning research that examined Nikor in conditions associated with acute or disruptive episodes, detailing the types of research conducted in this area. Nikor was studied for its use in periods of heightened symptoms. The main focus of this research examined outcomes describing episodic or acute changes and how quickly they were measured.

Studies report how symptoms evolved in the observed populations related to daily functioning or activity level during and immediately following an acute episode. The research describes patterns related to patient-reported outcomes. These studies contribute to the broader evidence landscape regarding how Nikor may be associated with managing acute changes.


Long-term Studies and Follow-up

Research has also examined evidence derived from settings with varying symptom burdens beyond the initial study period. However, the available data are still emerging, and long-term effects are not fully established. For many drugs, there is limited information for long-term outcomes due to the costs and duration of such research. While initial findings describe patterns observed in the studies for an extended duration, the certainty remains low for predicting results far into the future.


What is still uncertain about Nikor

A transparent review of the evidence shows that some areas still lack definitive research. For example, some findings were mixed across different studies. Areas where more research is needed include better comparisons against other treatments (as comparative evidence is lacking) and more research exploring the use of Nikor in specific populations where sample sizes were modest. This evidence highlights what is known — and what is still uncertain — about Nikor.

Frequently Asked Questions (FAQ)

Common questions about Nikor (FAQ)

Q: Why does Nikor sometimes cause a feeling of warmth or redness (flushing)?

A: Flushing, a feeling of warmth or redness, is a common and documented side effect of Nikor. Official product information indicates this effect is mechanistically linked to the drug's purpose as a peripheral arterial vasodilator. By widening the blood vessels, the drug causes increased blood flow near the surface of the skin, which results in the sensation of warmth.

Q: Why do doctors recommend avoiding alcohol and hot drinks when taking Nikor?

A: Regulatory information advises caution regarding alcohol consumption while taking Nikor. Alcohol can cause additive effects by further lowering blood pressure, which may increase the risk of side effects such as lightheadedness, dizziness, or fainting. Regulatory documents do not contain specific warnings regarding hot drinks, but the vasodilating nature of the drug suggests that high temperatures might potentially increase the risk of symptoms like dizziness.

Q: How often are liver function tests usually needed while on Nikor therapy?

A: Nikor is metabolized extensively by the liver, and patients with hepatic impairment require caution and often a reduced starting dose. For this reason, periodic monitoring of liver function may be recommended by a healthcare provider. A specific monitoring frequency is not universally mandated across all official labels. The need for and scheduling of these tests are determined by the prescribing healthcare provider based on established guidelines.

Q: Can Nikor be used long-term, or is it typically a short-term treatment?

A: Official information confirms that Nikor is a long-acting medication and is prescribed for chronic, once-daily oral administration. Due to its long half-life, it is intended for consistent, long-term use to manage conditions like high blood pressure and angina.

Q: Can a patient with a history of kidney disease safely take Nikor?

A: According to official regulatory documents, kidney impairment does not significantly change how the body handles Nikor. Typically, no dosage adjustment is required for patients with pre-existing kidney disease. Consultation with a healthcare provider is recommended before starting this or any new medication, particularly for individuals with a history of severe kidney issues.

Q: Is the initial headache from Nikor common, and how long does it typically persist?

A: Headache is officially documented as a common side effect of Nikor and is specifically noted to occur more often at the beginning of treatment. Generally, this side effect is expected to resolve, with some official sources indicating that initial headaches usually go away after the first week of therapy.

Q: Are there alternative ways to manage the flushing besides taking aspirin?

A: Official patient information suggests several lifestyle actions that may help manage flushing. These include simple measures like keeping the room cool, using a fan, and reducing intake of beverages such as coffee, tea, and alcohol.

Q: Is Nikor ever used for conditions other than high cholesterol and triglycerides?

A: Yes, Nikor's active ingredient, Amlodipine, is primarily indicated for managing cardiovascular conditions. Its official uses include treating high blood pressure (hypertension) and specific types of angina (chest pain), which are related to its main purpose as a calcium channel blocker.

Q: Why do some people take Nikor with a low-fat snack?

A: Official guidelines state that Nikor may be taken with or without food as food does not significantly impact its absorption. While not required, taking the dose with a light meal or snack can sometimes help minimize minor gastrointestinal side effects like nausea. Some individuals may choose to take their dose with food to help maintain a consistent daily schedule.

Q: What should I do if the side effects, like nausea, don't go away after a few weeks?

A: If common side effects such as nausea are persistent or become bothersome, official patient guidance advises contacting a healthcare provider. This consultation is recommended when symptoms continue beyond the initial adjustment period or interfere with daily life.

Q: Does Nikor have a risk of causing hypotension (low blood pressure)?

A: Yes, symptomatic hypotension, or low blood pressure that causes symptoms, is a documented risk. Official warnings note that a sudden drop in blood pressure is possible, particularly when treatment is first started or when the dosage is increased.

Q: How does the body eliminate or metabolize Nikor?

A: Regulatory documents indicate that Nikor is extensively metabolized—about 90% of the active ingredient is processed into inactive compounds, mainly by the liver. Only about 10% of the medication is eliminated from the body unchanged in the urine.

Q: Is Nikor safe to take if I am planning to become pregnant?

A: The safety of Nikor has not been established for use during pregnancy. A consultation with a healthcare provider is generally recommended for individuals planning a pregnancy to determine the appropriate course of action based on the health condition being treated.

Q: Can I take other pain relievers (like ibuprofen) while on Nikor?

A: Some common pain relievers, specifically non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, can potentially reduce the blood pressure-lowering effect of Nikor. The combined use may require closer monitoring of blood pressure, as outlined in official regulatory documentation regarding these drug classes.

Q: What are the signs of a serious liver problem I should watch for while taking Nikor?

A: Although rare, serious adverse events involving the liver have been documented. Official safety information advises watching for signs such as yellowing of the skin or eyes (jaundice), dark-colored urine, pale stools, or persistent, severe abdominal pain.

Q: Is it safe to suddenly stop taking Nikor without talking to a doctor first?

A: Official patient information recommends against suddenly stopping Nikor without first consulting with a healthcare provider. When discontinuation is necessary, it is generally recommended that the process be done gradually under medical supervision.

Q: What are the risks of taking Nikor if I have a history of stomach ulcers?

A: Nikor itself does not have a direct contraindication based on a history of stomach ulcers. However, since patients taking Nikor may also take pain relievers (NSAIDs), and NSAIDs carry risks for those with a history of ulcers, individuals with this history should consult with a healthcare provider about the potential risks.

Q: Does taking Nikor cause weight gain or weight loss?

A: Official clinical trial data indicates that weight gain has been reported as a less common side effect. It is important to note that this is often linked to oedema (swelling or fluid retention, typically in the ankles or feet), which is a very common side effect of the medication.

Q: How long does the flushing from Nikor usually last after taking a dose?

A: The exact duration of a single flushing episode is not precisely defined in regulatory labels. However, the flushing side effect is generally considered an initial reaction. For most patients, official information suggests the issue should go away after a few days of continued use as the body adjusts to the medication.

Q: Are there any foods I should specifically avoid while on Nikor?

A: Yes, official regulatory documents specifically advise avoiding Grapefruit or Grapefruit Juice. Consumption of these products is documented to increase the plasma concentration of Nikor in the bloodstream, which could heighten the risk of side effects.

How should Nikor be stored and disposed of?

Storage and Disposal of Nikor (Amlodipine)

Nikor tablets, which contain the active ingredient Amlodipine, must be stored strictly according to official regulatory guidelines.

Storage Requirements

Requirement Official Instruction
Temperature Store at controlled room temperature, between 20 C and 25 C.
Protection Protect the medicine from excessive moisture and light.
Container Keep the tablets in their original container and ensure it is tightly closed.
Safety Keep the product out of the sight and reach of children and pets.

Disposal

Unused or expired Nikor must not be disposed of via wastewater or household trash. The official protocol requires taking the medicine to a medicine take-back program for safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nikor found in:

A-Z Index: